β-catenin市场：按类型、应用和地区划分

预计到 2026 年，β-catenin 市值将达到 35.94 亿美元，到 2033 年将达到 68.22 亿美元。预计从 2026 年到 2033 年，其复合年增长率将达到 11.2%。

β-连环蛋白对胚胎生长发育至关重要。人类CTNNB1基因编码β-连环蛋白。此蛋白具有两种功能，也称为β-连环蛋白-1，参与细胞调控、基因转录和细胞黏附。此外，该蛋白促进细胞黏附，这对骨骼和皮肤等结构的形成至关重要。细胞内基因的活性受某些β-连环蛋白的调控。 β-连环蛋白透过与称为转录因子的特定分子结合发挥作用，转录因子与去氧核糖核酸（DNA）结合，影响胚胎发育为完整人体的过程。此外，β-连环蛋白也调控细胞分裂和增生。 β-连环蛋白是细胞核内经典Wnt讯号路径的关键核效应分子，也是钙黏蛋白介导的黏附连接的结构成分。 β-连环蛋白的结构和讯号失衡通常会导致与转移和癌症相关的疾病，以及增殖功能障碍。经典 Wnt 级联反应的主要效应因子是 β-catenin，它将讯号传递到细胞核，并触发 Wnt特异性基因的转录，这些基因调节各种细胞和器官的细胞命运决定。

市场动态

预计在预测期内，市场上的主要企业将推动市场成长，而癌症患者数量的不断增加是主要驱动力。例如，根据美国癌症协会2022年1月发布的数据，2022年美国约有106,180例大肠癌病例。此外，根据世界卫生组织（WHO）2021年3月发布的数据，2020年全球有230万名女性被诊断出罹患乳癌，其中68.5万人死于乳癌。

本报告的主要特点

• 本报告对全球β-catenin市场进行了详细分析，包括预测期（2026-2033年）的市场规模和复合年增长率，以2025年为基准年。
• 此外，它还确定了每个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
• 此外，它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
• 本节根据以下参数介绍全球β-catenin市场的主要企业概况：公司概况、产品系列、主要亮点、财务绩效和策略。
• 本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
• 《全球β-连环蛋白市场》报告面向该行业的众多相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过分析全球β-catenin市场中使用的各种策略矩阵来促进决策。

目录

第一章：分析目标与假设

• 分析目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章：市场动态、监管与趋势分析

• 市场动态
  • 促进因素
  • 阻碍因素
  • 市场机会
• 影响分析
• 市场趋势
• 主要进展
• 产品核准
• 商业伙伴关係、企业合併与收购 (M&A)
• 监理情势
• PEST分析
• 波特五力分析
• 流行病学
• 固体管道分析

第四章：全球β-连环蛋白市场：依类型划分（2026-2033年）

• BBI-801
• 埃克塞林德
• M-101
• 盐酸奈福泮
• 其他的

第五章：全球β-连环蛋白市场：依应用领域划分（2026-2033年）

• 皮肤病
• 瘤
• 遗传性疾病
• 其他的

第六章 全球β-连环蛋白市场：依地区划分（2026-2033年）

• 北美洲
  • 我们
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
• 中东
  • 波湾合作理事会（GCC）国家
  • 以色列
  • 其他中东国家
• 非洲
  • 北非
  • 中非
  • 南非

第七章 竞争情势

• 热图分析
• 市占率分析
• 公司简介
  • Boston Biomedical Inc
  • Dicerna Pharmaceuticals Inc.
  • Marina Biotech Inc.
  • Propanac Biopharma Inc
  • Warp Drive Bio Inc.
  • prism pharma co ltd
  • aileron therapeutics inc
  • MD2 Biosciences Inc
  • WntRx Pharmaceuticals Inc
  • Sapience Therapeutics Inc
  • Venn Therapeutics LLC

第八章

• 参考
• 分析方法
• 关于 Coherent Market Insights

Beta Catenin Market is estimated to be valued at USD 3,594 Mn in 2026 and is expected to reach USD 6,822 Mn by 2033, growing at a compound annual growth rate (CAGR) of 11.2% from 2026 to 2033.

A protein called beta-catenin is crucial for growth and development of embryos. The CTNNB1 gene in humans encodes the protein catenin beta. It is a protein with two functions that is also known as beta-catenin 1 and is involved in the control and coordination of cells, gene transcription, and cell adhesion. Additionally, it promotes cell adhesion, which is essential for the development of structures like bones and skin. The activity of genes in cells is regulated in part by beta-catenin. It functions by attaching to certain molecules known as transcription factors, which bind to Deoxyribonucleic acid (DNA) and influence how an embryo grows into a fully formed human being. Additionally, beta catenin regulates cell division and growth (proliferation). B-catenin is a crucial nuclear effector of canonical Wntsignaling in the nucleus and a structural component of cadherin-based adherens junctions. B-catenin structural and signaling imbalance frequently causes sickness and dysfunctional growth linked to metastasis and cancer. The primary effector in the canonical Wnt cascade is B-catenin, which transmits the signal to the nucleus and causes transcription of Wnt-specific genes that regulate cell fate decisions in a variety of cells and organs.

Market Dynamics

Key players operating in market are expected to drive the market growth during the forecast period, owing to increase in cancer patients. For instance, according to data published in January 2022, by the American Cancer Society, in 2022 in the U.S., there are about 106,180 cases of colon cancer. Moreover, according to data published on March 2021, by World Health Organization, states that, in 2020, there were 2.3 million women diagnosed with breast cancer globally and 685 000 deaths globally.

Key features of the study

• This report provides in-depth analysis of the global beta catenin market , and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global beta catenin market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Boston Biomedical Inc, Dicerna Pharmaceuticals Inc., Marina Biotech Inc., Propanac Biopharma Inc, Warp Drive Bio Inc., prism pharma co ltd, , aileron therapeutics inc, MD2 Biosciences Inc, WntRx Pharmaceuticals Inc, Sapience Therapeutics Inc, and Venn Therapeutics LLC
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global beta catenin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global beta catenin market

Market Segmentation

• By Type
  • BBI-801,
  • Exisulind
  • M-101
  • Nefopam Hydrochloride
  • Others
• By Application
  • Dermatology
  • Oncology
  • Genetic Disorder
  • Others
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Key Players
  • Boston Biomedical Inc
  • Dicerna Pharmaceuticals Inc.
  • Marina Biotech Inc.
  • Propanac Biopharma Inc
  • Warp Drive Bio Inc.
  • prism pharma co ltd.,
  • aileron therapeutics inc.,
  • MD2 Biosciences Inc.,
  • WntRx Pharmaceuticals Inc.,
  • Sapience Therapeutics Inc.,
  • Venn Therapeutics LLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Application
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Product Approval
• Collaboration/Merge/Acquisition
• Regulatory Landscape
• PEST Analysis
• Porter's Five Forces Analysis
• Epidemiology
• Robust Pipeline Analysis

4. Global Beta Catenin Market, By Type, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026- 2033
  • Segment Trends
• BBI-801
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Exisulind
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• M-101
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Nefopam Hydrochloride
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global Beta Catenin Market, By Application, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Dermatology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Genetic Disorder
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global Beta Catenin Market, By Region, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2026-2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis
• Company Profile
  • Boston Biomedical Inc
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Dicerna Pharmaceuticals Inc.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Marina Biotech Inc.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Propanac Biopharma Inc
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Warp Drive Bio Inc.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • prism pharma co ltd
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • aileron therapeutics inc
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • MD2 Biosciences Inc
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • WntRx Pharmaceuticals Inc
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Sapience Therapeutics Inc
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Venn Therapeutics LLC
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
• Analyst Views

8. Section

• References
• Research Methodology
• About Us